ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Aminoglycosides Antibiotics Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-23W8840
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Aminoglycosides Antibiotics Market Outlook 2022
BUY CHAPTERS

Global Aminoglycosides Antibiotics Market Research Report 2024

Code: QYRE-Auto-23W8840
Report
April 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Jemicare
TEVA
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla Ltd
Pfizer Inc
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company

Aminoglycosides Antibiotics Market Size

The global Aminoglycosides Antibiotics market was valued at US$ 758 million in 2023 and is anticipated to reach US$ 682 million by 2030, witnessing a CAGR of -1.2% during the forecast period 2024-2030.

Aminoglycosides Antibiotics Market

Aminoglycosides Antibiotics Market

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms.
The key players of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis and Fangyuan-pharma. The top four manufacturers hold approximately 15% of the global market share,.
In terms of product type, Tobramycin is the largest segment, with a share of 34%. And in terms of application, Hospital has a share about 38 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aminoglycosides Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aminoglycosides Antibiotics.
The Aminoglycosides Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Aminoglycosides Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aminoglycosides Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Aminoglycosides Antibiotics Market Report

Report Metric Details
Report Name Aminoglycosides Antibiotics Market
Accounted market size in 2023 US$ 758 million
Forecasted market size in 2030 US$ 682 million
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Etimicin
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Aminoglycosides Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Aminoglycosides Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Aminoglycosides Antibiotics Market size in 2030?

Ans: The Aminoglycosides Antibiotics Market size in 2030 will be US$ 682 million.

What is the market share of major companies in Aminoglycosides Antibiotics Market?

Ans: The top four manufacturers hold approximately 15% of the global market share,.

What is the Aminoglycosides Antibiotics Market share by type?

Ans: In terms of product type, Tobramycin is the largest segment, with a share of 34%.

Who are the main players in the Aminoglycosides Antibiotics Market report?

Ans: The main players in the Aminoglycosides Antibiotics Market are Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company

What are the Application segmentation covered in the Aminoglycosides Antibiotics Market report?

Ans: The Applications covered in the Aminoglycosides Antibiotics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Aminoglycosides Antibiotics Market report?

Ans: The Types covered in the Aminoglycosides Antibiotics Market report are Tobramycin, Gentamicin, Amikacin, Etimicin, Others

1 Aminoglycosides Antibiotics Market Overview
1.1 Product Definition
1.2 Aminoglycosides Antibiotics by Type
1.2.1 Global Aminoglycosides Antibiotics Market Value Comparison by Type (2024-2030)
1.2.2 Tobramycin
1.2.3 Gentamicin
1.2.4 Amikacin
1.2.5 Etimicin
1.2.6 Others
1.3 Aminoglycosides Antibiotics by Application
1.3.1 Global Aminoglycosides Antibiotics Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Aminoglycosides Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Aminoglycosides Antibiotics Revenue 2019-2030
1.4.2 Global Aminoglycosides Antibiotics Sales 2019-2030
1.4.3 Global Aminoglycosides Antibiotics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Aminoglycosides Antibiotics Market Competition by Manufacturers
2.1 Global Aminoglycosides Antibiotics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Aminoglycosides Antibiotics Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Aminoglycosides Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aminoglycosides Antibiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aminoglycosides Antibiotics, Product Type & Application
2.7 Global Key Manufacturers of Aminoglycosides Antibiotics, Date of Enter into This Industry
2.8 Global Aminoglycosides Antibiotics Market Competitive Situation and Trends
2.8.1 Global Aminoglycosides Antibiotics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Aminoglycosides Antibiotics Players Market Share by Revenue
2.8.3 Global Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aminoglycosides Antibiotics Market Scenario by Region
3.1 Global Aminoglycosides Antibiotics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Aminoglycosides Antibiotics Sales by Region: 2019-2030
3.2.1 Global Aminoglycosides Antibiotics Sales by Region: 2019-2024
3.2.2 Global Aminoglycosides Antibiotics Sales by Region: 2025-2030
3.3 Global Aminoglycosides Antibiotics Revenue by Region: 2019-2030
3.3.1 Global Aminoglycosides Antibiotics Revenue by Region: 2019-2024
3.3.2 Global Aminoglycosides Antibiotics Revenue by Region: 2025-2030
3.4 North America Aminoglycosides Antibiotics Market Facts & Figures by Country
3.4.1 North America Aminoglycosides Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Aminoglycosides Antibiotics Sales by Country (2019-2030)
3.4.3 North America Aminoglycosides Antibiotics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aminoglycosides Antibiotics Market Facts & Figures by Country
3.5.1 Europe Aminoglycosides Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Aminoglycosides Antibiotics Sales by Country (2019-2030)
3.5.3 Europe Aminoglycosides Antibiotics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aminoglycosides Antibiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Aminoglycosides Antibiotics Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Aminoglycosides Antibiotics Sales by Region (2019-2030)
3.6.3 Asia Pacific Aminoglycosides Antibiotics Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aminoglycosides Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Aminoglycosides Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Aminoglycosides Antibiotics Sales by Country (2019-2030)
3.7.3 Latin America Aminoglycosides Antibiotics Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aminoglycosides Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Aminoglycosides Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Aminoglycosides Antibiotics Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aminoglycosides Antibiotics Sales by Type (2019-2030)
4.1.1 Global Aminoglycosides Antibiotics Sales by Type (2019-2024)
4.1.2 Global Aminoglycosides Antibiotics Sales by Type (2025-2030)
4.1.3 Global Aminoglycosides Antibiotics Sales Market Share by Type (2019-2030)
4.2 Global Aminoglycosides Antibiotics Revenue by Type (2019-2030)
4.2.1 Global Aminoglycosides Antibiotics Revenue by Type (2019-2024)
4.2.2 Global Aminoglycosides Antibiotics Revenue by Type (2025-2030)
4.2.3 Global Aminoglycosides Antibiotics Revenue Market Share by Type (2019-2030)
4.3 Global Aminoglycosides Antibiotics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Aminoglycosides Antibiotics Sales by Application (2019-2030)
5.1.1 Global Aminoglycosides Antibiotics Sales by Application (2019-2024)
5.1.2 Global Aminoglycosides Antibiotics Sales by Application (2025-2030)
5.1.3 Global Aminoglycosides Antibiotics Sales Market Share by Application (2019-2030)
5.2 Global Aminoglycosides Antibiotics Revenue by Application (2019-2030)
5.2.1 Global Aminoglycosides Antibiotics Revenue by Application (2019-2024)
5.2.2 Global Aminoglycosides Antibiotics Revenue by Application (2025-2030)
5.2.3 Global Aminoglycosides Antibiotics Revenue Market Share by Application (2019-2030)
5.3 Global Aminoglycosides Antibiotics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Jemicare
6.1.1 Jemicare Company Information
6.1.2 Jemicare Description and Business Overview
6.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jemicare Aminoglycosides Antibiotics Product Portfolio
6.1.5 Jemicare Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Aminoglycosides Antibiotics Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Aminoglycosides Antibiotics Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Fangyuan-pharma
6.4.1 Fangyuan-pharma Company Information
6.4.2 Fangyuan-pharma Description and Business Overview
6.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio
6.4.5 Fangyuan-pharma Recent Developments/Updates
6.5 Aike Pharmaceutical
6.5.1 Aike Pharmaceutical Company Information
6.5.2 Aike Pharmaceutical Description and Business Overview
6.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio
6.5.5 Aike Pharmaceutical Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Aminoglycosides Antibiotics Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Pfizer Aminoglycosides Antibiotics Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Fresenius Kabi
6.8.1 Fresenius Kabi Company Information
6.8.2 Fresenius Kabi Description and Business Overview
6.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio
6.8.5 Fresenius Kabi Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Company Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharma Aminoglycosides Antibiotics Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 Hikma
6.10.1 Hikma Company Information
6.10.2 Hikma Description and Business Overview
6.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hikma Aminoglycosides Antibiotics Product Portfolio
6.10.5 Hikma Recent Developments/Updates
6.11 Lannett Company
6.11.1 Lannett Company Company Information
6.11.2 Lannett Company Description and Business Overview
6.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lannett Company Aminoglycosides Antibiotics Product Portfolio
6.11.5 Lannett Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aminoglycosides Antibiotics Industry Chain Analysis
7.2 Aminoglycosides Antibiotics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aminoglycosides Antibiotics Production Mode & Process
7.4 Aminoglycosides Antibiotics Sales and Marketing
7.4.1 Aminoglycosides Antibiotics Sales Channels
7.4.2 Aminoglycosides Antibiotics Distributors
7.5 Aminoglycosides Antibiotics Customers
8 Aminoglycosides Antibiotics Market Dynamics
8.1 Aminoglycosides Antibiotics Industry Trends
8.2 Aminoglycosides Antibiotics Market Drivers
8.3 Aminoglycosides Antibiotics Market Challenges
8.4 Aminoglycosides Antibiotics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Jemicare
TEVA
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla Ltd
Pfizer Inc
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company
List of Tables
 Table 1. Global Aminoglycosides Antibiotics Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Aminoglycosides Antibiotics Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Aminoglycosides Antibiotics Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Aminoglycosides Antibiotics Sales (M Units) of Key Manufacturers (2019-2024)
 Table 5. Global Aminoglycosides Antibiotics Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Aminoglycosides Antibiotics Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Aminoglycosides Antibiotics Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Aminoglycosides Antibiotics Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Aminoglycosides Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Aminoglycosides Antibiotics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Aminoglycosides Antibiotics, Product Type & Application
 Table 12. Global Key Manufacturers of Aminoglycosides Antibiotics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Aminoglycosides Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Aminoglycosides Antibiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Aminoglycosides Antibiotics Sales by Region (2019-2024) & (M Units)
 Table 18. Global Aminoglycosides Antibiotics Sales Market Share by Region (2019-2024)
 Table 19. Global Aminoglycosides Antibiotics Sales by Region (2025-2030) & (M Units)
 Table 20. Global Aminoglycosides Antibiotics Sales Market Share by Region (2025-2030)
 Table 21. Global Aminoglycosides Antibiotics Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2019-2024)
 Table 23. Global Aminoglycosides Antibiotics Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2025-2030)
 Table 25. North America Aminoglycosides Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Aminoglycosides Antibiotics Sales by Country (2019-2024) & (M Units)
 Table 27. North America Aminoglycosides Antibiotics Sales by Country (2025-2030) & (M Units)
 Table 28. North America Aminoglycosides Antibiotics Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Aminoglycosides Antibiotics Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Aminoglycosides Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Aminoglycosides Antibiotics Sales by Country (2019-2024) & (M Units)
 Table 32. Europe Aminoglycosides Antibiotics Sales by Country (2025-2030) & (M Units)
 Table 33. Europe Aminoglycosides Antibiotics Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Aminoglycosides Antibiotics Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Aminoglycosides Antibiotics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Aminoglycosides Antibiotics Sales by Region (2019-2024) & (M Units)
 Table 37. Asia Pacific Aminoglycosides Antibiotics Sales by Region (2025-2030) & (M Units)
 Table 38. Asia Pacific Aminoglycosides Antibiotics Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Aminoglycosides Antibiotics Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Aminoglycosides Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Aminoglycosides Antibiotics Sales by Country (2019-2024) & (M Units)
 Table 42. Latin America Aminoglycosides Antibiotics Sales by Country (2025-2030) & (M Units)
 Table 43. Latin America Aminoglycosides Antibiotics Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Aminoglycosides Antibiotics Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Aminoglycosides Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2019-2024) & (M Units)
 Table 47. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2025-2030) & (M Units)
 Table 48. Middle East and Africa Aminoglycosides Antibiotics Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Aminoglycosides Antibiotics Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Aminoglycosides Antibiotics Sales (M Units) by Type (2019-2024)
 Table 51. Global Aminoglycosides Antibiotics Sales (M Units) by Type (2025-2030)
 Table 52. Global Aminoglycosides Antibiotics Sales Market Share by Type (2019-2024)
 Table 53. Global Aminoglycosides Antibiotics Sales Market Share by Type (2025-2030)
 Table 54. Global Aminoglycosides Antibiotics Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Aminoglycosides Antibiotics Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2019-2024)
 Table 57. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2025-2030)
 Table 58. Global Aminoglycosides Antibiotics Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Aminoglycosides Antibiotics Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Aminoglycosides Antibiotics Sales (M Units) by Application (2019-2024)
 Table 61. Global Aminoglycosides Antibiotics Sales (M Units) by Application (2025-2030)
 Table 62. Global Aminoglycosides Antibiotics Sales Market Share by Application (2019-2024)
 Table 63. Global Aminoglycosides Antibiotics Sales Market Share by Application (2025-2030)
 Table 64. Global Aminoglycosides Antibiotics Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Aminoglycosides Antibiotics Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2019-2024)
 Table 67. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2025-2030)
 Table 68. Global Aminoglycosides Antibiotics Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Aminoglycosides Antibiotics Price (US$/Unit) by Application (2025-2030)
 Table 70. Jemicare Company Information
 Table 71. Jemicare Description and Business Overview
 Table 72. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Jemicare Aminoglycosides Antibiotics Product
 Table 74. Jemicare Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Teva Aminoglycosides Antibiotics Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Novartis Aminoglycosides Antibiotics Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. Fangyuan-pharma Company Information
 Table 86. Fangyuan-pharma Description and Business Overview
 Table 87. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Fangyuan-pharma Aminoglycosides Antibiotics Product
 Table 89. Fangyuan-pharma Recent Developments/Updates
 Table 90. Aike Pharmaceutical Company Information
 Table 91. Aike Pharmaceutical Description and Business Overview
 Table 92. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Aike Pharmaceutical Aminoglycosides Antibiotics Product
 Table 94. Aike Pharmaceutical Recent Developments/Updates
 Table 95. Cipla Company Information
 Table 96. Cipla Description and Business Overview
 Table 97. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Cipla Aminoglycosides Antibiotics Product
 Table 99. Cipla Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Pfizer Aminoglycosides Antibiotics Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Fresenius Kabi Company Information
 Table 106. Fresenius Kabi Description and Business Overview
 Table 107. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Fresenius Kabi Aminoglycosides Antibiotics Product
 Table 109. Fresenius Kabi Recent Developments/Updates
 Table 110. Sun Pharma Company Information
 Table 111. Sun Pharma Description and Business Overview
 Table 112. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Sun Pharma Aminoglycosides Antibiotics Product
 Table 114. Sun Pharma Recent Developments/Updates
 Table 115. Hikma Company Information
 Table 116. Hikma Description and Business Overview
 Table 117. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Hikma Aminoglycosides Antibiotics Product
 Table 119. Hikma Recent Developments/Updates
 Table 120. Lannett Company Company Information
 Table 121. Lannett Company Description and Business Overview
 Table 122. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Lannett Company Aminoglycosides Antibiotics Product
 Table 124. Lannett Company Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Aminoglycosides Antibiotics Distributors List
 Table 128. Aminoglycosides Antibiotics Customers List
 Table 129. Aminoglycosides Antibiotics Market Trends
 Table 130. Aminoglycosides Antibiotics Market Drivers
 Table 131. Aminoglycosides Antibiotics Market Challenges
 Table 132. Aminoglycosides Antibiotics Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Aminoglycosides Antibiotics
 Figure 2. Global Aminoglycosides Antibiotics Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Aminoglycosides Antibiotics Market Share by Type: 2023 & 2030
 Figure 4. Tobramycin Product Picture
 Figure 5. Gentamicin Product Picture
 Figure 6. Amikacin Product Picture
 Figure 7. Etimicin Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Aminoglycosides Antibiotics Market Value by Application (2024-2030) & (US$ Million)
 Figure 10. Global Aminoglycosides Antibiotics Market Share by Application: 2023 & 2030
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Others
 Figure 14. Global Aminoglycosides Antibiotics Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Aminoglycosides Antibiotics Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Aminoglycosides Antibiotics Sales (2019-2030) & (M Units)
 Figure 17. Global Aminoglycosides Antibiotics Average Price (US$/Unit) & (2019-2030)
 Figure 18. Aminoglycosides Antibiotics Report Years Considered
 Figure 19. Aminoglycosides Antibiotics Sales Share by Manufacturers in 2023
 Figure 20. Global Aminoglycosides Antibiotics Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Aminoglycosides Antibiotics Players: Market Share by Revenue in Aminoglycosides Antibiotics in 2023
 Figure 22. Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Aminoglycosides Antibiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Aminoglycosides Antibiotics Sales Market Share by Country (2019-2030)
 Figure 25. North America Aminoglycosides Antibiotics Revenue Market Share by Country (2019-2030)
 Figure 26. U.S. Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Aminoglycosides Antibiotics Sales Market Share by Country (2019-2030)
 Figure 29. Europe Aminoglycosides Antibiotics Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Aminoglycosides Antibiotics Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Aminoglycosides Antibiotics Revenue Market Share by Region (2019-2030)
 Figure 37. China Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Indonesia Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Thailand Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Malaysia Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Latin America Aminoglycosides Antibiotics Sales Market Share by Country (2019-2030)
 Figure 47. Mexico Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Brazil Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Argentina Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share by Country (2019-2030)
 Figure 51. Middle East and Africa Aminoglycosides Antibiotics Revenue Market Share by Country (2019-2030)
 Figure 52. Turkey Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Saudi Arabia Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. UAE Aminoglycosides Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Global Sales Market Share of Aminoglycosides Antibiotics by Type (2019-2030)
 Figure 56. Global Revenue Market Share of Aminoglycosides Antibiotics by Type (2019-2030)
 Figure 57. Global Aminoglycosides Antibiotics Price (US$/Unit) by Type (2019-2030)
 Figure 58. Global Sales Market Share of Aminoglycosides Antibiotics by Application (2019-2030)
 Figure 59. Global Revenue Market Share of Aminoglycosides Antibiotics by Application (2019-2030)
 Figure 60. Global Aminoglycosides Antibiotics Price (US$/Unit) by Application (2019-2030)
 Figure 61. Aminoglycosides Antibiotics Value Chain
 Figure 62. Aminoglycosides Antibiotics Production Process
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions